Improve walking balance via aquatherapy
- Trial ID
- NCT07390825
- Official Title
- Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
- Goal
- Improve walking balance via aquatherapy
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Ankara City Hospital Bilkent
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease
- Interventions
- Aquatherapy, home exercise
Plain-Language Summary
The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.
Locations
- Bilkent City Hospital, Çankaya, Ankara, Turkey (Türkiye)
- Bilkent City Hospital, Ankara, ÇANKAYA, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Aquatherapy. The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 7 months.